Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13159) 13159
Publication (1859) 1859
Book Review (121) 121
Book Chapter (114) 114
Newsletter (45) 45
Magazine Article (32) 32
Conference Proceeding (29) 29
Report (23) 23
Dissertation (19) 19
Book / eBook (17) 17
Government Document (4) 4
Newspaper Article (2) 2
Trade Publication Article (2) 2
Reference (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8835) 8835
index medicus (6265) 6265
immunology (4872) 4872
female (4151) 4151
infant (4056) 4056
conjugate vaccine (3941) 3941
children (3794) 3794
vaccines (3718) 3718
infectious diseases (3662) 3662
male (3446) 3446
child, preschool (3428) 3428
vaccination (3197) 3197
immunization (2870) 2870
child (2825) 2825
disease (2484) 2484
pneumococcal conjugate vaccine (2294) 2294
immunogenicity (2182) 2182
streptococcus-pneumoniae (2150) 2150
animals (2127) 2127
vaccines, conjugate - immunology (2051) 2051
pneumonia (2046) 2046
streptococcus pneumoniae (2046) 2046
microbiology (2021) 2021
adult (1966) 1966
pneumococcal infections - prevention & control (1959) 1959
pediatrics (1951) 1951
adolescent (1920) 1920
epidemiology (1813) 1813
medicine, research & experimental (1793) 1793
pneumococcal vaccines - immunology (1650) 1650
pneumococcal vaccines - administration & dosage (1543) 1543
infants (1539) 1539
conjugate vaccines (1519) 1519
pneumococcal infections - epidemiology (1471) 1471
meningitis (1443) 1443
mice (1416) 1416
streptococcus pneumoniae - immunology (1356) 1356
united-states (1356) 1356
vaccines, conjugate - administration & dosage (1336) 1336
antibodies, bacterial - blood (1334) 1334
serotyping (1317) 1317
middle aged (1231) 1231
prevention (1214) 1214
infant, newborn (1213) 1213
streptococcus pneumoniae - classification (1195) 1195
infections (1178) 1178
antibodies (1174) 1174
streptococcus pneumoniae - isolation & purification (1154) 1154
incidence (1135) 1135
aged (1130) 1130
research (1124) 1124
pneumococcal infections - microbiology (1122) 1122
health aspects (1087) 1087
vaccine (1082) 1082
efficacy (1067) 1067
safety (1030) 1030
allergy and immunology (1022) 1022
streptococcus infections (1000) 1000
age (992) 992
heptavalent pneumococcal conjugate vaccine (973) 973
bacterial pneumonia (964) 964
analysis (932) 932
polysaccharides (911) 911
risk factors (886) 886
antigens (871) 871
serotypes (858) 858
mortality (832) 832
young adult (829) 829
adults (818) 818
polysaccharides, bacterial - immunology (815) 815
impact (805) 805
proteins (801) 801
immunization schedule (788) 788
surveillance (772) 772
meningococcal vaccines - immunology (759) 759
medicine, general & internal (747) 747
pneumococcal infections - immunology (743) 743
streptococcus pneumoniae - drug effects (738) 738
influenzae type-b (727) 727
carriage (723) 723
capsular polysaccharide (721) 721
pneumococcal vaccine (707) 707
public health (706) 706
haemophilus vaccines - immunology (696) 696
pharmacology & pharmacy (696) 696
vaccines, conjugate (691) 691
research article (686) 686
pneumococcal vaccines (661) 661
nasopharyngeal carriage (659) 659
polysaccharide vaccine (658) 658
immunoglobulin g - blood (652) 652
invasive pneumococcal disease (643) 643
bacteria (637) 637
medicine (627) 627
acute otitis-media (626) 626
medical research (624) 624
meningococcal vaccines - administration & dosage (617) 617
studies (597) 597
article (595) 595
prevalence (589) 589
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12697) 12697
Spanish (199) 199
French (184) 184
German (102) 102
Russian (42) 42
Portuguese (28) 28
Polish (26) 26
Czech (22) 22
Hungarian (16) 16
Chinese (15) 15
Italian (14) 14
Japanese (11) 11
Dutch (8) 8
Korean (6) 6
Swedish (5) 5
Norwegian (4) 4
Slovak (4) 4
Turkish (3) 3
Finnish (2) 2
Hebrew (2) 2
Persian (2) 2
Danish (1) 1
Icelandic (1) 1
Romanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26–27 October 2016, Oxford, UK
by Meiring, James E and Gibani, Malick and Basnyat, Buddha and Bentsi-Enchill, Adwoa D and Clemens, John and Darton, Thomas C and Date, Kashmira and Dougan, Gordon and Garrett, Denise and Gessner, Bradford D and Gordon, Melita A and Heyderman, Robert S and Hombach, Joachim and Kotloff, Karen L and Levine, Myron M and Luby, Stephen P and Mohan, Vadrevu Krishna and Marfin, Anthony A and Mulholland, Kim and Neuzil, Kathleen and Pitzer, Virginia E and Pollard, Andrew J and Qadri, Firdausi and Salisbury, David and Zaidi, Anita and TyVAc Consortium Meeting Grp and TyVAC Consortium Meeting Group
Vaccine, ISSN 0264-410X, 09/2017, Volume 35, Issue 38, pp. 5081 - 5088
Typhoid fever is estimated to cause between 11.9–26.9 million infections globally each year with 129,000–216,510 deaths. Access to improved water sources have... 
Policy | Clinical trials | Global health | Effectiveness | Vaccines | Typhoid | MEDICINE, RESEARCH & EXPERIMENTAL | MULTICENTER | INFECTIONS | SAFETY | IMMUNOLOGY | CHILDREN | CLUSTER RANDOMIZED-TRIAL | ASIA | DISEASE BURDEN | INFANTS | NEW-GENERATION | VI CONJUGATE | Vaccines, Conjugate - immunology | Congresses as Topic | Vaccines, Conjugate - therapeutic use | Humans | Typhoid-Paratyphoid Vaccines - therapeutic use | Typhoid Fever - prevention & control | Clinical Trials as Topic | Typhoid Fever - immunology | Typhoid-Paratyphoid Vaccines - immunology | Medical research | Analysis | Vaccination | Medicine, Experimental | Typhoid fever | Epidemiology | Public health | Low income groups | Water-borne diseases | Pneumonia | Working groups | Disease | Licenses | Incidence | Consortia | Design | Ebola virus | Hepatitis | Cost effectiveness | Mathematical models | Children | Age | Immunization | Decision making | Population characteristics | Mortality | Fever | Studies | Charities | Population (statistical) | Tetanus | Cost analysis | Acceleration
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age
by Greenberg, Richard N and Gurtman, Alejandra and Frenck, Robert W and Strout, Cynthia and Jansen, Kathrin U and Trammel, James and Scott, Daniel A and Emini, Emilio A and Gruber, William C and Schmoele-Thoma, Beate
Vaccine, ISSN 0264-410X, 2014, Volume 32, Issue 20, pp. 2364 - 2374
Highlights • Conjugate pneumococcal polysaccharide vaccine allows for recall immune response. • This recall response occurs after follow-on use of conjugate or... 
Allergy and Immunology | Recall responses | Pneumococcal conjugate vaccine | Adult | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNOLOGICAL MEMORY | SAFETY | OLDER | IMMUNOLOGY | HYPORESPONSIVENESS | RESPONSES | IMMUNOGENICITY | MEMORY B-CELLS | YOUNG | REVACCINATION | ELDERLY ADULTS | Vaccines, Conjugate - administration & dosage | Streptococcus pneumoniae - classification | Double-Blind Method | Humans | Middle Aged | Pneumococcal Infections - prevention & control | Female | Immunization Schedule | Male | Pneumococcal Vaccines - administration & dosage | Phagocytosis | Medical colleges | Polysaccharides | Vaccines | Confidence intervals | Pneumonia | Disease | Alcoholism | Mortality | Muscle pain | Age | Fever
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text From empiricism to rational design: A personal perspective of the evolution of vaccine development
by De Gregorio, Ennio and Rappuoli, Rino
Nature Reviews Immunology, ISSN 1474-1733, 2014, Volume 14, Issue 7, pp. 505 - 514
Vaccination, which is the most effective medical intervention that has ever been introduced, originated from the observation that individuals who survived a... 
PNEUMOCOCCAL CONJUGATE VACCINE | PREVENT HIV-1 INFECTION | HEPATITIS-B-VACCINE | MEASLES-VIRUS VACCINE | YELLOW-FEVER VACCINE | CANDIDATE ANTIGENS | CELL-MEDIATED-IMMUNITY | IN-WATER EMULSION | INFLUENZA VACCINE | IMMUNOLOGY | REVERSE VACCINOLOGY | Plague Vaccine - history | History, Ancient | Adjuvants, Immunologic - pharmacology | History, 21st Century | Vaccination - history | History, 20th Century | History, Medieval | Humans | Smallpox - prevention & control | AIDS Vaccines - immunology | Vaccines, DNA - immunology | Vaccines - immunology | Vaccines - history | Communicable Disease Control | Influenza Vaccines - immunology | Glycoconjugates - immunology | Malaria Vaccines - immunology | Influenza Vaccines - history | Tuberculosis Vaccines - immunology | Smallpox - immunology | Plague Vaccine - immunology | Vaccines, DNA - history | Prevention | Medical research | Disease transmission | Medical case management | Medicine, Experimental | Forecasts and trends | Vaccines | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Immunogenicity and safety of the human rotavirus vaccine Rotarix ™ co-administered with routine infant vaccines following the vaccination schedules in Europe
by Vesikari, Timo and Karvonen, Aino and Prymula, Roman and Schuster, Volker and Tejedor, Juan C and Thollot, Franck and Garcia-Corbeira, Pilar and Damaso, Silvia and Han, Htay-Htay and Bouckenooghe, Alain
Vaccine, ISSN 0264-410X, 2010, Volume 28, Issue 32, pp. 5272 - 5279
Abstract This study assessed the immunogenicity and safety of a human rotavirus vaccine RIX4414; the effect of co-administration of childhood vaccines on the... 
Allergy and Immunology | Immune response | Safety | Rotavirus | Vaccination | Concomitant administration | MEDICINE, RESEARCH & EXPERIMENTAL | INTUSSUSCEPTION | EFFICACY | RIX4414 | IMMUNOLOGY | GASTROENTERITIS | LIVE | DISEASE | DOUBLE-BLIND | INFECTION | BURDEN | ENGLAND | Double-Blind Method | Rotavirus Vaccines - immunology | Poliovirus Vaccine, Inactivated - administration & dosage | Europe | Hepatitis B Vaccines - administration & dosage | Humans | Heptavalent Pneumococcal Conjugate Vaccine | Infant | Haemophilus Vaccines - administration & dosage | Pneumococcal Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Antibodies, Viral - blood | Vaccines, Attenuated - immunology | Vaccines, Attenuated - administration & dosage | Immunoglobulin A - blood | Rotavirus Vaccines - adverse effects | Diphtheria-Tetanus-acellular Pertussis Vaccines - administration & dosage | Immunization Schedule | Vaccines, Attenuated - adverse effects | Rotavirus Vaccines - administration & dosage | Cell culture | Hepatitis | Immunization | Viruses | Vaccines | Tetanus | Family medical history | Children & youth | Streptococcus infections
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized study
by Dbaibo, Ghassan and Tinoco Favila, Juan Carlos and Traskine, Magali and Jastorff, Archana and Van der Wielen, Marie
Vaccine, ISSN 0264-410X, 06/2018, Volume 36, Issue 28, pp. 4102 - 4111
Invasive meningococcal disease has a high burden in young children, particularly during infancy. We investigated the immunogenicity and safety of a... 
Co-administration | Quadrivalent meningococcal conjugate vaccine | Infants | Immunogenicity | Booster | MEDICINE, RESEARCH & EXPERIMENTAL | HUMAN IMMUNITY | W-135 | 2ND YEAR | NORTH-AFRICA | IMMUNOLOGY | CURRENT SITUATION | MENINGITIS | DISEASE | SEROGROUPS | LATIN-AMERICA | MIDDLE-EAST | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccines, Conjugate - adverse effects | Infant | Male | Haemophilus Vaccines - administration & dosage | Pneumococcal Vaccines - administration & dosage | Healthy Volunteers | Meningococcal Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - immunology | Drug-Related Side Effects and Adverse Reactions - pathology | Vaccines, Conjugate - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Female | Immunization Schedule | Pneumococcal Vaccines - adverse effects | Antibodies, Bacterial - blood | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Haemophilus Vaccines - immunology | Meningitis, Meningococcal - prevention & control | Drug-Related Side Effects and Adverse Reactions - epidemiology | Lebanon | Vaccines, Conjugate - administration & dosage | Pneumococcal Vaccines - immunology | Poliovirus Vaccine, Inactivated - adverse effects | Mexico | Meningococcal Vaccines - immunology | Meningococcal Vaccines - administration & dosage | Medicine, Experimental | Medical research | Meningitis | Safety and security measures | Vaccines | Vaccination | Schedules | Immune response | Diphtheria | Confidence intervals | Invasive meningococcal disease | Randomization | Poliomyelitis | Safety | Children | Tetanus | Age | Meningococcal disease
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Immunogenicity, Safety and Reactogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable H. influenzae Protein D Conjugate Vaccine Coadministered With DTPa-IPV-Hib in Dutch Children: A Randomized Controlled Trial
by van den Bergh, Menno R and Spijkerman, Judith and François, Nancy and Swinnen, Kristien and Borys, Dorota and Schuerman, Lode and Veenhoven, Reinier H and Sanders, Elisabeth A M
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 07/2016, Volume 35, Issue 7, pp. e206 - e219
BACKGROUND:Immune responses and safety profiles may be affected when vaccines are coadministered. We evaluated the immunogenicity, safety and reactogenicity of... 
IMMUNE-RESPONSE | INFECTIOUS DISEASES | BACTERIA | booster vaccination | DTPa-IPV-Hib coadministration | HAEMOPHILUS-INFLUENZAE | IMMUNOLOGY | CHILDHOOD VACCINES | immunogenicity | NASOPHARYNGEAL CARRIAGE | 10-valent pneumococcal conjugate vaccine | PROPHYLACTIC PARACETAMOL | STREPTOCOCCUS-PNEUMONIAE | reactogenicity | DISEASE | PEDIATRICS | NETHERLANDS | PHID-CV | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccines, Conjugate - adverse effects | Child, Preschool | Infant | Male | Haemophilus Vaccines - administration & dosage | Pneumococcal Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Poliovirus Vaccine, Inactivated - immunology | Immunoglobulin D - immunology | Vaccines, Conjugate - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Pneumococcal Infections - immunology | Immunization, Secondary | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Female | Pneumococcal Vaccines - adverse effects | Antibodies, Bacterial - blood | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Hepatitis B Vaccines - administration & dosage | Haemophilus Vaccines - immunology | Vaccines, Conjugate - administration & dosage | Vaccines, Combined - adverse effects | Hepatitis B Vaccines - adverse effects | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Poliovirus Vaccine, Inactivated - adverse effects | Antibodies, Viral - immunology | Hepatitis B Vaccines - immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix ™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children
by Knuf, Markus and Pantazi-Chatzikonstantinou, Anna and Pfletschinger, Ulrich and Tichmann-Schumann, Irmingard and Maurer, Hartwig and Maurer, Lothar and Fischbach, Thomas and Zinke, Henrike and Pankow-Culot, Heidemarie and Papaevangelou, Vassiliki and Bianco, Veronique and Van der Wielen, Marie and Miller, Jacqueline M
Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 25, pp. 4264 - 4273
Abstract Tetravalent meningococcal serogroups ACWY conjugate vaccines will provide an advantage to those at most risk of invasive meningococcal disease; namely... 
Allergy and Immunology | Tetravalent meningococcal vaccine | Hexavalent vaccine | Conjugate vaccine | DTaP-HBV-IPV/Hib combination vaccine | Bactericidal activity | MEDICINE, RESEARCH & EXPERIMENTAL | NEISSERIA-MENINGITIDIS | PREVENTION | IMMUNOSORBENT-ASSAY ELISA | SERUM ANTIBODIES | IMMUNOLOGY | PROTECTIVE LEVEL | TODDLERS | CAPSULAR POLYSACCHARIDE | IMPACT | INFLUENZAE TYPE-B | DISEASE | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccines, Conjugate - adverse effects | Infant | Male | Haemophilus Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Antibodies, Viral - blood | Meningococcal Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - immunology | Vaccines, Conjugate - immunology | Female | Diphtheria-Tetanus-acellular Pertussis Vaccines - adverse effects | Antibodies, Bacterial - blood | Diphtheria-Tetanus-acellular Pertussis Vaccines - immunology | Tetanus Toxoid - adverse effects | Haemophilus Vaccines - immunology | Tetanus Toxoid - administration & dosage | Vaccines, Conjugate - administration & dosage | Vaccines, Combined - adverse effects | Poliovirus Vaccine, Inactivated - adverse effects | Diphtheria-Tetanus-acellular Pertussis Vaccines - administration & dosage | Meningococcal Vaccines - immunology | Meningococcal Vaccines - administration & dosage | Tetanus Toxoid - immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)
by Knuf, Markus and Szenborn, Leszek and Moro, Masnuel and Petit, Christian and Bermal, Nancy and Bernard, Laurence and Dieussaert, Ilse and Schuerman, Lode
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 04/2009, Volume 28, Issue 4 Suppl, pp. S97 - S108
BACKGROUND:The choice of non-typeable Haemophilus influenzae Protein D as main carrier protein in the candidate 10-valent pneumococcal conjugate vaccine... 
Pneumococcal conjugate vaccine | DTPw-combined | Booster vaccination | Primary vaccination | DTPa-combined | Meningococcal conjugate vaccine | Streptococcus pneumoniae | HIB | INFECTIOUS DISEASES | LINKED-IMMUNOSORBENT-ASSAY | booster vaccination | primary vaccination | B VACCINE | SERUM ANTIBODIES | IMMUNOLOGY | PROTECTIVE LEVEL | CAPSULAR POLYSACCHARIDE | IMMUNIZATION | meningococcal conjugate vaccine | INFANTS | PEDIATRICS | NEISSERIA-MENINGITIDIS SEROGROUP | REACTOGENICITY | pneumococcal conjugate vaccine | Humans | Vaccination | Infant | Haemophilus Vaccines - administration & dosage | Pneumococcal Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Antibodies, Viral - blood | Immunoglobulin D - immunology | Vaccines, Conjugate - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Immunization, Secondary | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Immunization Programs | Immunization Schedule | Bacterial Proteins - immunology | Antibodies, Bacterial - blood | Carrier Proteins - immunology | Hepatitis B Vaccines - administration & dosage | Heptavalent Pneumococcal Conjugate Vaccine | Treatment Outcome | Poliovirus Vaccines - administration & dosage | Haemophilus Vaccines - immunology | Randomized Controlled Trials as Topic | Vaccines, Conjugate - administration & dosage | Pneumococcal Vaccines - immunology | Hepatitis B Vaccines - immunology | Meningococcal Vaccines - immunology | Poliovirus Vaccines - immunology | Lipoproteins - immunology | Meningococcal Vaccines - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants
by Vesikari, Timo and Borrow, Ray and Da Costa, Xavier and Richard, Patrick and Eymin, Cécile and Boisnard, Florence and Lockhart, Stephen
Vaccine, ISSN 0264-410X, 2016, Volume 35, Issue 3, pp. 452 - 458
Highlights • DTaP-IPV-HB-PRP-T immunogenicity is similar when given concomitantly with a meningococcal C conjugate vaccine or alone. • The safety profile of... 
Allergy and Immunology | Co-administration | Meningococcal C | Safety | Immunogenicity | Vaccination | Hexavalent | MEDICINE, RESEARCH & EXPERIMENTAL | DIFFERENCE | COMBINATION VACCINES | B VACCINE | IMMUNOLOGY | TETANUS TOXOID CONJUGATE | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Infant | Haemophilus Vaccines - administration & dosage | Pneumococcal Vaccines - administration & dosage | Healthy Volunteers | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Meningococcal Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - immunology | Hepatitis B Antibodies - blood | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Immunization Schedule | Antibodies, Bacterial - blood | Rotavirus Vaccines - administration & dosage | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Hepatitis B Vaccines - administration & dosage | Haemophilus Vaccines - immunology | Vaccines, Combined - adverse effects | Hepatitis B Vaccines - adverse effects | Finland | Poliovirus Vaccine, Inactivated - adverse effects | Hepatitis B Vaccines - immunology | Meningococcal Vaccines - immunology | Meningococcal Vaccines - administration & dosage | Usage | Infants | Vaccines | Antigens | Hepatitis | Immunization | Pain | Poliomyelitis | Viruses | Tetanus | Diphtheria | Age | Whooping cough
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years
by Schwarz, T.F and Flamaing, J and Rümke, H.C and Penzes, J and Juergens, C and Wenz, A and Jayawardene, D and Giardina, P and Emini, E.A and Gruber, W.C and Schmoele-Thoma, B
Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 32, pp. 5195 - 5202
Abstract This randomized, double-blind study evaluated concomitant administration of 13-valent pneumococcal conjugate vaccine (PCV13) and trivalent inactivated... 
Allergy and Immunology | 13-Valent pneumococcal conjugate vaccine | Safety | Immunogenicity | Europe | ANTIBODIES | MEDICINE, RESEARCH & EXPERIMENTAL | EFFICACY | OLDER-ADULTS | IMMUNOLOGY | CHILDREN | IMMUNE-RESPONSES | PHASE-1 TRIAL | DISEASE | POLYSACCHARIDE | Influenza Vaccines - administration & dosage | Double-Blind Method | Immunoglobulin G - blood | Humans | Vaccines, Conjugate - adverse effects | Influenza Vaccines - adverse effects | Polysaccharides, Bacterial - immunology | Male | Pneumococcal Vaccines - administration & dosage | Streptococcus pneumoniae - immunology | Vaccines, Conjugate - immunology | Influenza Vaccines - immunology | Aged, 80 and over | Pneumococcal Vaccines - immunology | Female | Immunization Schedule | Influenza A virus - immunology | Aged | Pneumococcal Vaccines - adverse effects | Placebos - administration & dosage | Influenza vaccines | Polysaccharides | Vaccination | Immunoglobulin G | Influenza | Clinical trials | Adults | Pneumonia | Vaccines | Older people
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Conjugate vaccines
by Cruse, Julius M and Lewis, R. E and Cruse, J. M
1989, Contributions to microbiology and immunology, ISBN 9783805549325, Volume 10., 196
Bacterial vaccines | Synthetic vaccines
Book
Details down arrow
12. Full Text Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine
by Ray Borrow and Nick Andrews and Helen Findlow and Pauline Waight and Joanna Southern and Annette Crowley-Luke and Lorraine Stapley and Anna England and Jamie Findlow and Elizabeth Miller
Clinical and Vaccine Immunology, ISSN 1556-6811, 01/2010, Volume 17, Issue 1, pp. 154 - 159
Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
CAPSULAR POLYSACCHARIDE | INFECTIOUS DISEASES | HUMAN IMMUNITY | IMMUNOGENICITY | ASSAY | PROTECTION | MICROBIOLOGY | IMMUNOLOGY | ENGLAND | CHILDREN | Immunoglobulin G - blood | Humans | Infant | Haemophilus Vaccines - administration & dosage | Haemophilus influenzae type b - immunology | Pneumococcal Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Mumps Vaccine - immunology | Vaccines, Conjugate - immunology | Rubella Vaccine - immunology | Vaccination - methods | Time Factors | Antibodies, Bacterial - blood | Mumps Vaccine - administration & dosage | Heptavalent Pneumococcal Conjugate Vaccine | Immunization, Secondary - methods | Measles Vaccine - administration & dosage | United Kingdom | Haemophilus Vaccines - immunology | Vaccines, Conjugate - administration & dosage | Rubella Vaccine - administration & dosage | Measles Vaccine - immunology | Pneumococcal Vaccines - immunology | Meningococcal Vaccines - immunology | Meningococcal Vaccines - administration & dosage | Adolescence | Rubella | Immunoglobulin G | Data processing | Infants | Vaccines | Immunity | Measles | Phosphate | Mathematical models | Children | Kinetics | Mumps | Tetanus | Age | Vaccine Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ⩾60-year-old adults
by Song, Joon Young and Cheong, Hee Jin and Hyun, Hak Jun and Seo, Yu Bin and Lee, Jacob and Wie, Seong-Heon and Choi, Min Joo and Choi, Won Suk and Noh, Ji Yun and Yun, Jae Won and Yun, Jin Gu and Kim, Woo Joo
Vaccine, ISSN 0264-410X, 2016, Volume 35, Issue 2, pp. 313 - 320
Highlights • No immune interference was observed when PCV13 and MF59-aTIV were given together. • The immunogenicity criteria of influenza vaccine was met... 
Allergy and Immunology | Pneumococcal conjugate vaccine | MF59 | Influenza vaccine | Emulsion adjuvant | TRIAL | MEDICINE, RESEARCH & EXPERIMENTAL | STREPTOCOCCUS-PNEUMONIAE | OLDER-ADULTS | ELDERLY SUBJECTS | IMMUNOLOGY | POLYSACCHARIDE VACCINE | SEASON | Influenza Vaccines - administration & dosage | Adjuvants, Immunologic - administration & dosage | Humans | Middle Aged | Male | Pneumococcal Vaccines - administration & dosage | Adjuvants, Immunologic - adverse effects | Hemagglutination Inhibition Tests | Drug Interactions | Aged, 80 and over | Polysorbates - administration & dosage |